Literature DB >> 18539649

The role of systemic handling in the pathophysiologic actions of botulinum toxin.

Fetweh H Al-Saleem1, Denise M Ancharski, Easwaran Ravichandran, Suresh G Joshi, Ajay K Singh, Yujing Gong, Lance L Simpson.   

Abstract

The ability of botulinum toxin to poison cholinergic nerve transmission is a dynamic phenomenon that involves not only the actions of the toxin on the body but also the actions of the body on the toxin. The former has been the subject of intense research, whereas the latter has received almost no attention. Therefore, a series of studies were performed to characterize systemic handling of botulinum toxin. The results indicated that the toxin reaches the general circulation (transcytosis across epithelial cells) without obvious changes in structure or biological activity. The general circulation acts as a holding compartment until there is adequate fractional distribution to neuromuscular junctions to produce blockade of transmission. During its transit through this compartment, the toxin 1) undergoes little biotransformation, 2) does not accumulate significantly in circulating cells, and 3) remains largely in the free state. In naive animals, the t(1/2) for toxin in the general circulation is approximately 10 h, and at any given point in time, there is little uptake in nontarget organs (liver, kidney, heart, and lung). In immunized animals, toxin clearance from the general circulation is rapid, and there is substantial accumulation of antibody-antigen complexes in liver. Thus, enhanced clearance from the circulation is a major mechanism by which active immunization can protect against poisoning.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18539649     DOI: 10.1124/jpet.108.136242

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Substrates and controls for the quantitative detection of active botulinum neurotoxin in protease-containing samples.

Authors:  Karine Bagramyan; Bruce E Kaplan; Luisa W Cheng; Jasmin Strotmeier; Andreas Rummel; Markus Kalkum
Journal:  Anal Chem       Date:  2013-05-22       Impact factor: 6.986

2.  Analysis of the mechanisms that underlie absorption of botulinum toxin by the inhalation route.

Authors:  Fetweh H Al-Saleem; Denise M Ancharski; Suresh G Joshi; M Elias; Ajay Singh; Zidoon Nasser; Lance L Simpson
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

3.  Identification of the factors that govern the ability of therapeutic antibodies to provide postchallenge protection against botulinum toxin: a model for assessing postchallenge efficacy of medical countermeasures against agents of bioterrorism and biological warfare.

Authors:  Fetweh H Al-Saleem; Zidoon Nasser; Rebecca M Olson; Linsen Cao; Lance L Simpson
Journal:  J Pharmacol Exp Ther       Date:  2011-05-17       Impact factor: 4.030

4.  Localization of the sites and characterization of the mechanisms by which anti-light chain antibodies neutralize the actions of the botulinum holotoxin.

Authors:  Tsuyoshi Takahashi; Suresh G Joshi; Fetweh Al-Saleem; Denise Ancharski; Ajay Singh; Zidoon Nasser; Lance L Simpson
Journal:  Vaccine       Date:  2009-02-24       Impact factor: 3.641

5.  Antibody protection against botulinum neurotoxin intoxication in mice.

Authors:  Luisa W Cheng; Larry H Stanker; Thomas D Henderson; Jianlong Lou; James D Marks
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

6.  Efficient serum clearance of botulinum neurotoxin achieved using a pool of small antitoxin binding agents.

Authors:  Jorge Sepulveda; Jean Mukherjee; Saul Tzipori; Lance L Simpson; Charles B Shoemaker
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

7.  Cellular Protection of SNAP-25 against Botulinum Neurotoxin/A: Inhibition of Thioredoxin Reductase through a Suicide Substrate Mechanism.

Authors:  Hajime Seki; Song Xue; Sabine Pellett; Peter Šilhár; Eric A Johnson; Kim D Janda
Journal:  J Am Chem Soc       Date:  2016-04-20       Impact factor: 15.419

8.  Enhanced neutralization potency of botulinum neurotoxin antibodies using a red blood cell-targeting fusion protein.

Authors:  Sharad P Adekar; Andrew T Segan; Cindy Chen; Rodney Bermudez; M D Elias; Bernard H Selling; B P Kapadnis; Lance L Simpson; Paul M Simon; Scott K Dessain
Journal:  PLoS One       Date:  2011-03-02       Impact factor: 3.240

9.  Obturator nerve block with botulinum toxin type B for patient with adductor thigh muscle spasm -a case report-.

Authors:  Eun Joo Choi; Jong Min Byun; Francis Sahngun Nahm; Pyung Bok Lee
Journal:  Korean J Pain       Date:  2011-09-06

10.  Use of Monoclonal Antibodies in the Sensitive Detection and Neutralization of Botulinum Neurotoxin Serotype B.

Authors:  Luisa W Cheng; Thomas D Henderson; Tina I Lam; Larry H Stanker
Journal:  Toxins (Basel)       Date:  2015-11-27       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.